Octave Group is a venture capital firm focused on early-stage AI, data infrastructure, privacy and enterprise software opportunities. It invests in the United States and also has later-stage venture exposure in biotechnology, life sciences and pharmaceuticals, making it most relevant for founders in enterprise data and AI/privacy markets, with some fit for later-stage life sciences financings.